drugset
drugset / Trial / NCT01830283

The Safety, Immunogenicity and Immune Effect Research of the Varicella Vaccine After the 2nd Dose Vaccination

NCT01830283 ↗

Phase 4 Unknown 50000 enrolled Beijing Center for Disease Control and Prevention
Non-randomizedParallel-groupOpen-labelPrevention

Summary

To investigate the safety, immunogenicity and immune effect of the Varicella vaccine after the 2nd dose vaccination in Chao yang district, Bei jing, since the 2nd varicella vaccination was promoted by Beijing Center for Disease Control and Prevention in November, 2012.

Timeline

Start
2013-04
Primary completion
2013-06
Completion
2018-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Varicella vaccine Vaccine — —

Indications

chickenpox